Latest Commercial Rollout News

Lumos Diagnostics has expanded FebriDx deployment to 265 US healthcare sites across 29 states, while product revenue rose 224% in the first quarter. The commercial gains came alongside a US$4.7 million operating cash outflow, slower-than-planned paediatric study enrolment and a Hologic development timeline pushed to around June 2028.

Wide Open Agriculture has extended Univar Solutions China’s exclusive distribution rights for its lupin protein products through 2028, preserving a route into the mainland Chinese market. But the agreement is not a purchase order: revenue depends first on WOA restoring commercial supply through contract manufacturing.

Argent BioPharma has granted Thai Phytomed International exclusive global commercialisation rights to four cannabis genotypes under a 10-year agreement. The deal preserves Argent’s ownership, but royalties depend on TPI generating profitable sales and securing approvals across multiple markets.

ReNerve has reported its strongest quarter yet, with sales climbing to $584,000 as the medical device company expands across Asia-Pacific. The growth came alongside a secured funding drawdown, leaving the company with $1.62 million in cash but continued negative operating cash flow.

Yojee has expanded its MOSAIC freight software customer base to 17 signed agreements, with five customers now processing live jobs after the platform’s July commercial launch. The company has $11.2 million in cash and no debt, but must now turn early usage into billable activity.

Zoono Group has advanced retailer, packaging and shipping-container programs across several markets, but ended the September quarter with just NZ$77,000 in cash. The company estimates funding for 0.67 quarters and says further funding lines or an equity raise may be required if customer receipts do not accelerate.

Swift TV has agreed to extend its fully drawn $5.53 million secured facility by 12 months, giving it until March 2028 to repay the debt. The extension comes with a higher interest rate, a capitalised fee and 100 million warrants for lender Pure Asset Management, and still requires ASX clearance or shareholder approval.

FirstWave Cloud Technology has secured an approximately A$1.06 million placement to fund sales conversion and the launch of Open-AudIT 7 and an AI fault-diagnosis product. The raise follows a sharp reduction in losses, positive operating cash flow and a lower cost base, but adds about 151.3 million shares to the register.

Klevo Group has reported a sharp FY2026 turnaround, with revenue up 324%, positive operating cash flow and cash rising to A$4.32 million. The more striking claim is its KLVR stablecoin platform, which has recorded USD 59.2 million in unaudited revenue since trial commencement ahead of a planned commercial rollout.

Yojee enters FY27 with 12 signed MOSAIC customer agreements and $10.45 million in fresh funding, but the freight software company is still loss-making and yet to generate meaningful MOSAIC revenue. Management expects initial billings in the December quarter as it works to convert signed customers into live, billable usage.

Compumedics Limited (ASX:CMP) returned to profit in FY26 as record revenue, stronger cash generation and a sharp rise in MEG and SaaS sales reshaped its earnings profile. The company enters FY27 with A$28.3 million of open orders, but lower gross margins and uneven US and European execution remain key tests.

Memphasys will receive an A$3.5 million advance from major shareholder Peters Investments to expand Felix production, inventory and sales capacity as repeat orders emerge across international markets. The funding carries a 12.5% interest rate, potential equity dilution and requires shareholder and ASX approvals before the convertible notes can be issued.